The easiest way to acquire a 12-lead ECG, making critical data accessible in more places, more often.
Learn how Kardia 12L can transform your practice.
For healthcare professional use only
Reimagining the 12-lead ECG experience.
We challenged our engineers, clinicians, and data scientists to rethink the 12-lead ECG. The resulting technology underscores our commitment to transform cardiovascular care — simplifying and expediting access to critical cardiac data.
See How
One-cable design + AI trained with one million ECGs.
The FDA-cleared Kardia 12L is an AI-powered handheld 12-lead resting ECG system. With simplified leadset technology, Kardia 12L offers outstanding clinical efficiency that expands access to 12-lead recordings in more settings than ever before.
Its unique single-cable design makes lead placement more intuitive and less error-prone, so even qualified personnel with infrequent ECG experience can acquire an accurate recording in minutes.
And with 1 million ECGs from leading U.S. medical institutions, our team developed a robust algorithm with multiple deep neural network AI models. The Kardia 12L ECG algorithm received FDA 510(k) clearance by demonstrating substantial equivalence to the state-of-the-art 12-lead ECG algorithm.
1. Get started with the KardiaStation app
2. Record a 12-lead ECG
3. Share ECGs for quick review
Lead placement options
Electrodes can be placed on the supine patient in either the Default or Alternate lead set locations. The KardiaStation app will guide you to select the appropriate lead placement, based on patient symptoms. Ensure Right Arm lead is placed first in order for the Leads Off function to display properly.
none
Comparison to conventional 12-lead results
Standard 12-lead ECG vs. Kardia 12L ECG report
Recent data presented at Heart Rhythm Society 2024, "Diagnostic accuracy of a mobile, artificial intelligence-guided, 12-lead ECG device," showed results from a clinical study on 200 patients. See the side-by-side ECG reports from a standard 12-lead compared to one from the Kardia 12L for the same patients.
The study found that Kardia 12L enabled rapid acquisition of resting ECG information, and concluded "this approach has significant implications for rapid ECG diagnosis in clinical practice."
The poster can be accessed here.
none
none
none
Normal Sinus Rhythm
Sinus Rhythm
Atrial Fibrillation
Atrial Flutter
1st Degree AV Block
High degree AV block (including 2nd and 3rd degree AV blocks)
Sinus Arrhythmia
Marked Sinus Arrhythmia
Paced Rhythm
Marked Bradycardia (SR, Bradycardia)
Junctional Rhythm
Sinus Tachycardia (SR, Tachycardia)
Bigeminy
PVCs
Right bundle branch block (RBBB)
Left bundle branch block (LBBB)
Other Intraventricular Block
Left Ventricle Hypertrophy (LVH)
Right Ventricle Hypertrophy (RVH)
Right Atrial Enlargement (RAE)
Left Atrial Enlargement (LAE)
Old Anterior MI
Old Inferior MI
Old Lateral MI
Acute Anterior MI
Acute Inferior MI
Acute Lateral MI
Anterior Ischemia
Inferior Ischemia
Lateral Ischemia
Early Repolarization
Prolonged QT
Paced ECG
Wolff-Parkinson-White (WPW)
Normal ECG
The provisional automated ECG analysis should not be used for clinical action if it has not been reviewed by a healthcare professional qualified to independently interpret the ECG signal. The four synthesized chest leads are not intended for diagnostic use
View the 2025 Kardia 12L Coding Guidelines here.
To learn more about Kardia 12L, download our free guide.
Legal
1Whyte, Seabrook, et al. "Diagnostic accuracy of a mobile, artificial intelligence-guided, 12-lead ECG device." Poster presented at: Heart Rhythm Society 2024; May 16-19, 2024; Boston MA, USA.
2The provisional automated ECG analysis should not be used for clinical action if it has not been reviewed by a healthcare professional qualified to independently interpret the ECG signal. The four synthesized chest leads are not intended for diagnostic use
Kardia 12L is intended for use by qualified healthcare professionals or trained personnel.
